FundedIQ
Biotechnology

Abselion: Funding, Investors & Team (Oct 2026)

Abselion is the biological sensor for rapid and cost-effective detection of biological substances like proteins, DNA, or small molecules.

www.abselion.com LinkedIn Cambridge, United Kingdom 1-10 employees
Total raised
$8.4M
Rounds
1
Latest
Series A
Dec 2024

Abselion has raised $8.4M across 1 funding round on record, the most recent a Series A of $8.4M announced in Dec 2024.

That round is in line with the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Abselion Company Profile and Key Stats

Total funding raised
$8.4M
across 1 round on record
Funding rounds on record
1
Latest funding round
Series A
$8.4M in Dec 2024
Employees
1-10
reported band
Headquarters
Cambridge, United Kingdom

Latest funding round on record: Dec 2024.

Abselion Funding Rounds

Date
Round
Amount
Series A
$8.4M

Abselion Founders and Leadership Team

Name
Role
Contact
Christoph V Bieberstein
Founder
—

No contact details are on record for this team yet.

Abselion Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.4M
5,368
$4.1M
8,591
$15M

Abselion's latest round of $8.4M is in line with the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Abselion in Biotechnology and Cambridge

Companies Similar to Abselion

Microbiotica develops treatments involving live bacteria found in the human microbiome, aiming to identify…

Series C $40.4M

OMass Technologies is a drug discovery company exploiting novel mass spectrometry platforms to develop…

Series C $310M

HydRegen, based in Oxford, UK, is a biotech firm that offers eco-friendly alternatives for the production of…

Series A $8.0M

R1 Therapeutics is a clinical‑stage biopharmaceutical company focused on discovering and developing new drug…

Series A $3.0M

The perfect package for any general surgical trainee or resident. Progress from beginner to advanced surgical…

Undisclosed round $9.3M

Argonaute RNA company research projects build on existing intellectual property.

Undisclosed round $1.8M

An innovative C elegans company that serves the biotech, nutrition, and other industries and fields of study…

Undisclosed round $1.8M

ViaNautis, previously known as SomaServe, was established in 2018 as a separate entity from UCL under the…

Undisclosed round $23.3M

Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…

Series A $33.6M

Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…

Undisclosed round $3.5M

Concert Bio helps businesses create optimal microbial communities.

Undisclosed round $130k

RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…

Series A $113M

Abselion Funding FAQs

What does Abselion do?

Abselion is the biological sensor for rapid and cost-effective detection of biological substances like proteins, DNA, or small molecules.

How much funding has Abselion raised?

Abselion has raised $8.4M across 1 round on record. The most recent is a Series A of $8.4M announced in Dec 2024.

When did Abselion last raise funding?

Abselion's most recent funding round on record is a Series A of $8.4M, announced in Dec 2024.

Who founded Abselion?

FundedIQ lists Christoph V Bieberstein (Founder) at Abselion.

Where is Abselion headquartered?

Abselion is based in Cambridge, Cambridgeshire, United Kingdom.

How many employees does Abselion have?

Abselion is in the 1-10 employee band.

How does Abselion's funding compare to other Biotechnology startups?

Abselion's latest round of $8.4M is in line with the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Abselion Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Abselion is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.